MangoRx Launches 'PRIME' By MangoRx, Powered By Kyzatrex FDA Approved Oral Testosterone Replacement Therapy Treatment
MangoRx Launches 'PRIME' By MangoRx, Powered By Kyzatrex FDA Approved Oral Testosterone Replacement Therapy Treatment
MangorX 推出 MangorX 的 “PRIME”，由 Kyzatrex FDA 批准的口服睾丸激素替代療法提供支持
The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatment to the Telehealth Market
這家總部位於達拉斯的直接面向消費者的遠程醫療公司將經美國食品藥品管理局批准的口服睾丸激素替代療法引入遠程醫療市場
Dallas, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product ('GROW') and erectile dysfunction (ED) drug ('Mango'), is excited to announce the highly anticipated release and availability of 'PRIME' by MangoRx, Powered by Kyzatrex ("PRIME") bringing the FDA-approved oral testosterone replacement therapy (TRT) treatment to consumers...
得克薩斯州達拉斯，2024年3月12日（GLOBE NEWSWIRE）——Mangoceuticals, Inc.（納斯達克股票代碼：MGRX）（“Mango...
登入免費觀看全文
登入/註冊